Enteroendocrine secretion after roux-en-Y gastric bypass: Is it important?

Research output: Contribution to journalArticle

5 Citations (Scopus)

Abstract

Observational studies suggest that bariatric surgery is the most effective intervention for achieving a significant and durable weight loss. In patients with type 2 diabetes, such surgery is often associated with remission of their diabetes. The mechanism(s) by which surgeries such as Roux-en-Y Gastric Bypass (RYGB) leads to favorable effects on glucose metabolism remain unknown. RYGB is associated with altered secretion of enteroendocrine hormones, leading to the belief that these hormones contribute to the improvement in insulin secretion and action as well as satiation after this procedure. However, it is important to consider the not insignificant effects of caloric restriction and the mechanical changes to the upper gut in determining the outcomes of such surgery.

Original languageEnglish (US)
Pages (from-to)1-3
Number of pages3
JournalNeurogastroenterology and Motility
Volume25
Issue number1
DOIs
StatePublished - Jan 2013

Fingerprint

Gastric Bypass
Hormones
Satiation
Caloric Restriction
Bariatric Surgery
Type 2 Diabetes Mellitus
Observational Studies
Weight Loss
Insulin
Glucose

Keywords

  • Dipeptidyl Peptidase-4
  • Enteroendocrine secretion
  • Glucagon-Like Peptide-1
  • Roux-en-Y Gastric Bypass

ASJC Scopus subject areas

  • Endocrine and Autonomic Systems
  • Gastroenterology
  • Physiology

Cite this

Enteroendocrine secretion after roux-en-Y gastric bypass : Is it important? / Vella, Adrian.

In: Neurogastroenterology and Motility, Vol. 25, No. 1, 01.2013, p. 1-3.

Research output: Contribution to journalArticle

@article{2717652c1df44b96a083293e7507798b,
title = "Enteroendocrine secretion after roux-en-Y gastric bypass: Is it important?",
abstract = "Observational studies suggest that bariatric surgery is the most effective intervention for achieving a significant and durable weight loss. In patients with type 2 diabetes, such surgery is often associated with remission of their diabetes. The mechanism(s) by which surgeries such as Roux-en-Y Gastric Bypass (RYGB) leads to favorable effects on glucose metabolism remain unknown. RYGB is associated with altered secretion of enteroendocrine hormones, leading to the belief that these hormones contribute to the improvement in insulin secretion and action as well as satiation after this procedure. However, it is important to consider the not insignificant effects of caloric restriction and the mechanical changes to the upper gut in determining the outcomes of such surgery.",
keywords = "Dipeptidyl Peptidase-4, Enteroendocrine secretion, Glucagon-Like Peptide-1, Roux-en-Y Gastric Bypass",
author = "Adrian Vella",
year = "2013",
month = "1",
doi = "10.1111/nmo.12048",
language = "English (US)",
volume = "25",
pages = "1--3",
journal = "Neurogastroenterology and Motility",
issn = "1350-1925",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Enteroendocrine secretion after roux-en-Y gastric bypass

T2 - Is it important?

AU - Vella, Adrian

PY - 2013/1

Y1 - 2013/1

N2 - Observational studies suggest that bariatric surgery is the most effective intervention for achieving a significant and durable weight loss. In patients with type 2 diabetes, such surgery is often associated with remission of their diabetes. The mechanism(s) by which surgeries such as Roux-en-Y Gastric Bypass (RYGB) leads to favorable effects on glucose metabolism remain unknown. RYGB is associated with altered secretion of enteroendocrine hormones, leading to the belief that these hormones contribute to the improvement in insulin secretion and action as well as satiation after this procedure. However, it is important to consider the not insignificant effects of caloric restriction and the mechanical changes to the upper gut in determining the outcomes of such surgery.

AB - Observational studies suggest that bariatric surgery is the most effective intervention for achieving a significant and durable weight loss. In patients with type 2 diabetes, such surgery is often associated with remission of their diabetes. The mechanism(s) by which surgeries such as Roux-en-Y Gastric Bypass (RYGB) leads to favorable effects on glucose metabolism remain unknown. RYGB is associated with altered secretion of enteroendocrine hormones, leading to the belief that these hormones contribute to the improvement in insulin secretion and action as well as satiation after this procedure. However, it is important to consider the not insignificant effects of caloric restriction and the mechanical changes to the upper gut in determining the outcomes of such surgery.

KW - Dipeptidyl Peptidase-4

KW - Enteroendocrine secretion

KW - Glucagon-Like Peptide-1

KW - Roux-en-Y Gastric Bypass

UR - http://www.scopus.com/inward/record.url?scp=84871656499&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84871656499&partnerID=8YFLogxK

U2 - 10.1111/nmo.12048

DO - 10.1111/nmo.12048

M3 - Article

C2 - 23279727

AN - SCOPUS:84871656499

VL - 25

SP - 1

EP - 3

JO - Neurogastroenterology and Motility

JF - Neurogastroenterology and Motility

SN - 1350-1925

IS - 1

ER -